Overview A Phase IIA Study of MK0457 in Patients With Cancer of the Lung (0457-006) Status: Terminated Trial end date: 2007-05-01 Target enrollment: Participant gender: Summary This is a study to evaluate the effectiveness of an investigational drug in patients with cancer of the lung. Phase: Phase 2 Details Lead Sponsor: Merck Sharp & Dohme Corp.